CASE REPORT: STRONGYLOIDES HYPERINFECTION SYNDROME IN A PATIENT WITH DRUG-INDUCED CUSHING’S SYNDROME DUE TO PROLONGED CORTICOSTEROID USE
Main Article Content
Abstract
Background: Strongyloidiasis is prevalent in tropical and subtropical regions. In immunocompromised individuals, infection with Strongyloides stercoralis can trigger Strongyloides hyperinfection syndrome (SHS), a severe condition that often carries a high mortality rate. We report a severe case of hyperinfection syndrome in an elderly patient with knee osteoarthritis whose prolonged use of anti-inflammatory corticosteroids led to drug-induced Cushing's syndrome and type 2 diabetes mellitus.
Results: A 74-year-old female patient from Long An province, with a history of long-term corticosteroid therapy for knee osteoarthritis, was admitted with progressive dyspnea and fatigue. Her respiratory distress worsened rapidly, requiring initial oxygen therapy via a reservoir mask, followed by endotracheal intubation and mechanical ventilation. Sputum and stool examinations revealed S. stercoralis larvae. Blood cultures were positive for Enterococcus faecium sensitive to vancomycin. Notably, the peripheral blood eosinophil count was within the normal range at the time of admission. During the clinical course, the patient developed severe pneumonia complicated by Acute Respiratory Distress Syndrome (ARDS) and upper gastrointestinal bleeding suspected to be due to peptic ulcer disease. Treatment included Ivermectin, combined with Meropenem and Vancomycin. The patient was successfully weaned from the ventilator after 9 days and was discharged in stable condition after 16 days of treatment.
Case presentation: Strongyloides hyperinfection syndrome in patients on long-term corticosteroid therapy presents a poor prognosis, often manifesting as ARDS and secondary sepsis. The absence of eosinophilia poses a significant diagnostic challenge and can lead to missed diagnoses. Proactive parasite screening prior to initiating immunosuppressive therapy, along with early administration of high-dose Ivermectin and intensive care support, are crucial to improving clinical outcomes.
Article Details
Keywords
Strongyloides hyperinfection syndrome, Strongyloides stercoralis, Enterococcus faecium, Pneumonia, ARDS.
References
[2] Quang HH, HV H. Hội chứng tăng nhiễm với ấu trùng giun lươn điển hình: Báo cáo ca bệnh và Tổng hợp y văn. Tạp chí Y học Thành phố Hồ Chí Minh. 2012;16(3):193.
[3] Hương NT LN. Báo cáo ca bệnh tăng nhiễm giun lươn điều trị khỏi bằng Thiabendazole đường uống. Y học thực hành. 2013;879(9):75-8.
[4] Vân TTH TP, Thủy VTT, Biên LHT, Yến HTH. Hội chứng tăng nhiễm giun lươn ở bệnh nhân sử dụng Corticosteroid Y Học TP Hồ Chí Minh. 2018;22.
[5] Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. 2004;17(1):208-17.
[6] Marcos LA, Terashima A, DuPont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2008;102(4):314-8.
[7] Fardet L, Généreau T, Poirot J-L, Guidet B, Kettaneh A, Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: Case series and literature review. Journal of Infection. 2007;54(1):18-27.
[8] Buonfrate D, Salas-Coronas J, Muñoz J, Maruri BT, Rodari P, Castelli F, et al. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. The Lancet Infectious Diseases. 2019;19(11):1181-90.
[9] Tuyền HT, Dũng NV, Thảo ĐTP, Đức PV, Minh PLT. Hội chứng tăng nhiễm ấu trùng giun lươn trên bệnh nhân phụ thuộc corticoid. Tạp chí Khoa học tiêu hóa Việt Nam. 2022;10(67).
[10] Trà ĐT, Hương PTT. Báo cáo ca bệnh nhiễm giun lươn tăng nhiễm đồng nhiễm với khuẩn huyết do E. Coli tại Bệnh viện Bạch Mai. Tạp chí Nghiên cứu Y học. 2025;194(9):764-72.
[11] Linh NT, Hương NTT. Báo cáo ca bệnh hạ natri máu do nhiễm giun lươn ở bệnh nhân suy thượng thận do thuốc. Tạp chí Nghiên cứu Y học. 2024;185(12):393-7.
[12] Hoàng BH, Luân ĐM, Chương NĐ, Duy BK, Phamarcy. Đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị ở bệnh nhân nhiễm giun lươn tại Bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh. Journal of 108-Clinical Medicine. 2024.
[13] Nguyễn TC, Đặng QT, Phạm NT. Đặc điểm lâm sàng, cận lâm sàng và điều trị bệnh nhân nhiễm Strongyloides stercoralis nặng ở bệnh viện Bệnh Nhiệt đới Trung Ương và bệnh viện Bạch Mai (2/2013 - 9/2019). Tạp chí Truyền nhiễm Việt Nam. 2020;1(29):49-53.
[14] Vadlamudi RS, Chi DS, Krishnaswamy GJC, Allergy M. Intestinal strongyloidiasis and hyperinfection syndrome. 2006;4:1-13.
[15] Rodpai R, Sanpool O, Thanchomnang T, Laoraksawong P, Sadaow L, Boonroumkaew P, et al. Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis. 2021;16(6):e0253701.
[16] Segarra-Newnham MJAoP. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. 2007;41(12):1992-2001.
[17] Woodring JH, Halfhill 2nd H, Reed JC. Pulmonary strongyloidiasis: clinical and imaging features. AJR American journal of roentgenology. 1994;162(3):537-42.
[18] Hegde U, Patel H, Chakurkar V. Acute respiratory distress syndrome due to strongyloides stercoralis in Lupus nephritis.
[19] SCOWDEN EB, SCHAFFNER W, STONE WJJM. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. 1978;57(6):527-44.
[20] Henriquez‐Camacho C, Gotuzzo E, Echevarria J, White Jr AC, Terashima A, Samalvides F, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database of Systematic Reviews. 2016(1).
[21] Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Current Opinion in Infectious Diseases. 2012;25(4).